Concepedia

Wai Kay Seto

WK

22

Publications

2.2K

Citations

19

H-Index

2009

Active since

Affiliations

University of Hong Kong(Current)

Queen Mary Hospital

Chinese University of Hong Kong

University College London

Auckland Institute of Studies

Wai Kay Seto is an author at University of Hong Kong specializing in medicine, hepatology, and hepatitis.

Top concepts

Publications per year

2009–2025

22

Publications

22

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 535 citations

, , +9

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 447 citations

, , +9

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 406 citations · Full text

, , +10

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma

Danny Wong, Fung Yu Huang, Ching‐Lung Lai et al. · Hepatology · 2011 · 154 citations · Full text

Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication

Ka Shing Cheung, Esther W. Chan, Angel Wong et al. · JNCI Journal of the National Cancer Institute · 2018 · 69 citations

Rows per page

1–5 of 22